Medorrinum C30.4 g

Pharmacotherapeutic group: Homeopathic medicine

Pharmacological action
This medicine is made from lysate of urethral secretions of gonorrhea patients taken before the start of treatment. It is prepared in compliance with the rules of viral safety*.

* Donors are selected according to the safety and health criteria approved by AFFSAP (French Medicines Safety Agency) for registration certificates for medicines made from donor material. These criteria are in accordance with the European guidelines.

Indications

Key symptoms for prescribing the drug
– growth of skin-mucous neoplasms: molluscum, condyloma, warts;
– abundant serous discharge from orifices, especially the vagina in women
– presence of catarrhal inflammation in one or more mucous membranes;
– slow and progressive development of various diseases;
– tendency to depression and even obsession as a reaction to the existing diseases.

Main cases of clinical use

1. – Otolaryngology

– Chronic rhinopharyngitis with enlargement of adenoids, which may be hypertrophied or not, abundant discharge, transparent.
– Exudative otitis media
– Prevention of recurrence of sore throat
– Chronic sinusitis, polyposis of the nose and sinuses

2. – Pulmonology

– Chronic bronchitis
– Treatment of chronic asthma

3. – Dermatology

– Diaper dermatitis
– Bad smelling sore eczema
– Herpes, especially genital
– Acne
– Small warts, plantar warts, merging warts on the cheeks
– Molluscum contagiosum, condylomas, papillomas.

4. – Urology

– Lingering urinary tract infections.
– Chronic prostatitis.
– Prevention of recurrence of polyposis of the bladder.

5 – Gynecology

– Chronic vaginitis.
– Gynecologic infections, in particular:
– HPV infections,
– Chlamydia: primary indication because this disease has identical location of lesions, both urethrovaginal and conjunctival, and pathogenetic symptoms characteristic of this substance.
– Uterine fibroids and intrauterine polyps: to limit the progression of the disease and prevent recurrence after their removal in women with recurrent urogenital infections.

6 – Rheumatology

– Degenerative or inflammatory rheumatism, especially in large joints with characteristic changes; pelvic rheumatoid spondylitis.
– Reactive arthritis, especially if there is a history of Fissenger-Leroy-Reuter syndrome, with symptoms similar to those of Medorrhinum (Medorrhinum).

7 – Behavioral disorders

– Sleep disturbances in children who make rhythmic head movements on the pillow when falling asleep, sleeping on their stomach or in a lap and elbow position.
– Difficulties learning in school due to memory problems or psychomotor agitation with disorderly accelerated movements.
– Some depressive and/or obsessive states.

Medorrhinum (Medorrhinum) has been used to treat depressive and/or obsessive states in adults after a chronic urinary tract infection requiring long-term treatment.

Composition

MEDORRHINUM (MEDORRHINUM)
C30

Excipients: sucrose, lactose.
4 g – pellet counter pouches (1) – cardboard boxes.

How to take, the dosage

Sublingually.

The pellets should be taken by mouth 30 minutes before a meal or 60 minutes after a meal.

Children from 0 to 3 years must first dilute the pellets by shaking them in 10-15 ml of water at room temperature and then give them to drink.

The optimal amount per oral dose is 5 pellets.

Please consult your doctor to determine the dilution, number and length of dosing.

Interaction

Special Instructions

Contraindications

Side effects

Overdose